INS and metabolic syndrome: Moreover, hepatic Aloxe3 expression mitigated diet-induced dyslipidemia, and db/db mice expressing Aloxe3 exhibited attenuated weight gain, enhanced basal caloric expenditure, and PPARγ-dependent insulin sensitivity.